• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


5.7100 USD 0.2700 4.96%

As of 17:20:00 ET on 07/29/2014.

Snapshot for Trevena Inc (TRVN)

Open: 5.4800 Day's Range: 5.4000 - 5.8800 Volume: 26,804
Previous Close: 5.4400 52wk Range: 4.0700 - 9.9499 1-Yr Rtn: -

Stock Chart for TRVN

No chart data available.
  • TRVN:US 5.7000
  • 1D
  • 1M
  • 1Y
Interactive TRVN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TRVN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.8500
Est. PEG Ratio -
Market Cap (M USD) 150.50
Shares Outstanding (M) 26.36
30 Day Average Volume 108,578
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TRVN

No data available

Company Profile & Key Executives for TRVN

Trevena, Inc. develops pharmaceutical products. The Company offers discovery and development of agents targeting G-protein coupled receptors and therapies and drugs that treat acute heart failure, post-operative pain, acute and chronic pain, and depression. Trevena serves customers throughout the United States.

Maxine GowenPresident/CEO/FounderRoberto CucaSenior VP/CFO
John M LimongelliSenior VP/Secretary/Gen CnslRosamond DeeganSenior VP:Business Development
More Company Profile & Key Executives for TRVN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil